Greene, Stephen J.
Fonarow, Gregg C.
Vaduganathan, Muthiah
Khan, Sadiya S.
Butler, Javed
Gheorghiade, Mihai
Article History
First Online: 10 February 2015
Change Date: 18 February 2015
Change Type: Correction
Change Details: In the version of this article initially published online, 'Rehospitalization' was misspelled in the title of Figure 1. The error has been corrected for the print, HTML, and PDF versions of the article.
Competing interests
: G.C.F. declares research support from the Agency for Healthcare Research and Quality and has been a consultant for Gambro, Medtronic, and Novartis. J.B. has received research support from the NIH, European Union, and Health Resources Service Administration, and is or has been a consultant for Amgen, Bayer, BG Medicine, Cardiocell, Celladon, Gambro, GE Healthcare, Medtronic, Novartis, Ono Pharma, Takeda, Trevena, and Zensun. M.G. is a consultant for Abbott Laboratories, Astellas, AstraZeneca, Bayer Schering Pharma AG, Cardiorentis, CorThera, Cytokinetics, CytoPherx Inc, DebioPharm SA, Errekappa Terapeutici, GlaxoSmithKline, Ikaria, Intersection Medical Inc, Johnson & Johnson, Medtronic, Merck, Novartis Pharma AG, Ono Pharmaceuticals USA, Otsuka Pharmaceuticals, Palatin Technologies, Pericor Therapeutics, Protein Design Laboratories, Sanofi-Aventis, Sigma Tau, Solvay Pharmaceuticals, Sticares InterACT, Takeda Pharmaceuticals North America, and Trevena Therapeutics. The other authors declare no competing interests.